Christine Lindenboom | VP, IR |
John Maraganore | CEO |
Barry Greene | President |
Akshay Vaishnaw | President of R&D |
Manmeet Soni | CFO |
Yvonne Greenstreet | COO |
Jeff Poulton | Incoming CFO |
Alethia Young | Cantor Fitzgerald |
Gena Wang | Barclays Capital |
Whitney Ijem | Guggenheim |
Anupam Rama | JPMorgan |
Ritu Baral | Cowen & Company |
Vincent Chen | Bernstein Research |
Edward Tenthoff | Piper Jaffray |
David Lebowitz | Morgan Stanley |
Ladies and gentlemen, thank you for standing by. Welcome to the Alnylam Pharmaceuticals' Conference Call to discuss Second Quarter 2019 Financial Earnings. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company's request.
I would now like to turn the call over to the company.